1-5 of 5
Andrew Dervan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Crowdsourced High-Risk Classifiers for Multiple Myeloma Patients Commonly Identify PHF19 As a Robust Progression Biomarker

Michael J Mason, PhD, Carolina D. Schinke, MD, Christine Eng, PhD, Fadi Towfic, PhD, Fred Gruber, PhD, Brian S. White, Yi Cui, PhD, Bailiang Li, PhD, Thomas Yu, BS, William S. Dalton, PhDMD, Hartmut Goldschmidt, MD, Herve Avet-Loiseau, MD PhD, Mehmet Samur, PhD, Maria Ortiz, Matthew Trotter, PhD, Boris Hayete, PhD, Andrew Dervan, Erin Flynt, Hongyue Dai, PhD, Douglas Bassett, PhD, Pieter Sonneveld, Kenneth H. Shain, MD PhD, Nikhil C. Munshi, MD, Daniel Auclair, Dirk Hose, MD, Gareth Morgan, MDPhDFRCP, Jonathan Göke, PhD, Brian A Walker, PhD, Anjan Thakurta, Justin Guinney, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4370.
https://doi.org/10.1182/blood-2019-127362
Published: 2019
Journal Articles

Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma

Mary H Young, PhD, Sam A Danziger, Alison Fitch, Frank Schmitz, MD PhD, Jake Gockley, PhD, Mark McConnell, PhD, David Reiss, PhD, Wilbert B. Copeland, PhD, Sarah K Johnson, PhD, Katie Newhall, PhD, Robert Hershberg, MD PhD, Teri Foy, PhD, Alexander Ratushny, PhD, Brian A Walker, PhD, Andrew Dervan, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 243.
https://doi.org/10.1182/blood-2018-99-113042
Published: 2018
Journal Articles

Immune Microenvironment Analysis of Bone Marrow By Mass Cytometry and RNA Sequencing in Multiple Myeloma Patients Treated with Daratumumab and Durvalumab

Frances Seymour, MRCP, BSc, MBBS, Mary H Young, PhD, Mark Tometsko, BSc, Jamie Cavenagh, MD PhD, Ethan G. Thompson, PhD, Elizabeth Whalen, PhD, Sam A Danziger, Alison Fitch, Brian A. Fox, PhD, Andrew Dervan, Teri Foy, PhD, Katie Newhall, PhD, John G. Gribben
Journal: Blood
Blood (2018) 132 (Supplement 1): 3296.
https://doi.org/10.1182/blood-2018-99-114453
Published: 2018
Journal Articles

Chromothripsis and Chromoplexy Are Associated with DNA Instability and Adverse Clinical Outcome in Multiple Myeloma

Cody Ashby, PhD, Michael A Bauer, PhD, Yan Wang, Christopher P. Wardell, PhD MSc, BSc, Ruslana G. Tytarenko, MS, Purvi Patel, Erin Flynt, Maria Ortiz, Andrew Dervan, Jake Gockley, PhD, Aneta Mikulasova, PhD, Carolina D. Schinke, MD, Sharmilan Thanendrarajan, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Jonathan J Keats, PhD, Daniel Auclair, PhD, Anjan Thakurta, PhD, Brian A Walker, PhD, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 408.
https://doi.org/10.1182/blood-2018-99-117359
Published: 2018
Journal Articles

Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies

Samuel A Danziger, PhD, Mark McConnell, PhD, Jake Gockley, PhD, Mary Young, PhD, Adam Rosenthal, MS, Frank Schmitz, MD PhD, David Reiss, PhD, Phil Farmer, Cody Ashby, PhD, Michael A Bauer, PhD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Maurizio Zangari, MD, Nathan Petty, MS, CCRP, Wilbert B. Copeland, PhD, Brian A. Fox, PhD, Antje Hoering, PhD, Alison Fitch, Katie Newhall, PhD, Bart Barlogie, MD PhD, Brian A Walker, PhD, Matthew Trotter, PhD, Rob Hershberg, MD PhD, Andrew Dervan, Alexander Ratushny, PhD, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1882.
https://doi.org/10.1182/blood-2018-99-113169
Published: 2018